OpenAlex
PricingAboutJobs
Log inGet started
Work

Small molecules as therapeutic drugs for Alzheimer's disease

HTML

Year: 2019
Type: review
Source: Molecular and Cellular Neuroscience
DOI: 10.1016/j.mcn.2019.03.001
Authors: Darryll M.A. Oliver, P. Hemachandra Reddy
Institutions: Texas Tech University, Texas Tech University Health Sciences Center
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: Alzheimer's disease, mitochondrial dysfunction, mitochondria-targeted antioxidants, MitoQ, MitoTEMPO, MCAT, DDQ, amyloid-beta, oxidative stress, reactive oxygen species, mitochondrial DNA damage, blood-brain barrier, synaptic dysfunction, cognitive decline, cholinesterase inhibitors, glutamate receptor antagonists
SDG: Good health and well-being

Open Access status: green

Funders: Alzheimer's Association, CH Foundation, Garrison Family Foundation, National Institutes of Health, National Institute on Aging, National Institute of Neurological Disorders and Stroke
Awards: Small Molecule Inhibitor Therapeutic Target for Alzheimer's Disease., Mitochondrial Fragmentation and Neurodegeneration in Huntington's Disease, Dynamin-Related Protein 1 and Mitochondrial Fragmentation in Alzheimer's Disease, Voltage-Dependent Anion Channel and Neurodegeneration in Alzheimer's Disease
OpenAlex ID: W2921919999
FWCI: 2.131
Cites: 75
Cited by: 167
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security